Trials / Unknown
UnknownNCT03035344
Study of the Intermediate Metabolism in Children With Acute Lymphoblastic Leukemia (ALL)
Study of the Intermediate Metabolism in Children With Acute Lymphoblastic Leukemia
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 25 (estimated)
- Sponsor
- Aristotle University Of Thessaloniki · Academic / Other
- Sex
- All
- Age
- 1 Month – 16 Years
- Healthy volunteers
- Not accepted
Summary
Study of the intermediate metabolism in children diagnosed with ALL compared to healthy matched controls.
Detailed description
The primary cause of this study is to investigate the changes that ALL may cause to the metabolome of pediatric patients, in order to better understand its mechanism of action and target metabolic pathways for potential therapies.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Metabolome study | Metabolome study in ALL patients compared to healthy controls |
Timeline
- Start date
- 2015-05-01
- Primary completion
- 2017-05-01
- Completion
- 2018-11-01
- First posted
- 2017-01-30
- Last updated
- 2017-01-30
Locations
1 site across 1 country: Greece
Source: ClinicalTrials.gov record NCT03035344. Inclusion in this directory is not an endorsement.